Gut-liver interaction in triglyceride-rich lipoprotein metabolism
- 1 September 2011
- journal article
- review article
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 301 (3) , E429-E446
Abstract
The liver and intestine have complementary and coordinated roles in lipoprotein metabolism. Despite their highly specialized functions, assembly and secretion of triglyceride-rich lipoproteins (TRL; apoB-100-containing VLDL in the liver and apoB-48-containing chylomicrons in the intestine) are regulated by many of the same hormonal, inflammatory, nutritional, and metabolic factors. Furthermore, lipoprotein metabolism in these two organs may be affected in a similar fashion by certain disorders. In insulin resistance, for example, overproduction of TRL by both liver and intestine is a prominent component of and underlies other features of a complex dyslipidemia and increased risk of atherosclerosis. The intestine is gaining increasing recognition for its importance in affecting whole body lipid homeostasis, in part through its interaction with the liver. This review aims to integrate recent advances in our understanding of these processes and attempts to provide insight into the factors that coordinate lipid homeostasis in these two organs in health and disease.Keywords
This publication has 232 references indexed in Scilit:
- Acute suppression of apo B secretion by insulin occurs independently of MTPBiochemical and Biophysical Research Communications, 2011
- Diurnal Regulation of MTP and Plasma Triglyceride by CLOCK Is Mediated by SHPCell Metabolism, 2010
- Glucagon-Like Peptide-1 Receptor Is Present on Human Hepatocytes and Has A Direct Role in Decreasing Hepatic Steatosis in Vitro by Modulating Elements of the Insulin Signaling PathwayHepatology, 2010
- Coordinated regulation of the metabolome and lipidome at the host-microbial interfaceBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2010
- Specific role for acyl CoAHepatology, 2009
- The Glucagon Receptor Is Required for the Adaptive Metabolic Response to FastingCell Metabolism, 2008
- The Cholesterol Absorption Inhibitor Ezetimibe Acts by Blocking the Sterol-Induced Internalization of NPC1L1Cell Metabolism, 2008
- IRE1β Inhibits Chylomicron Production by Selectively Degrading MTP mRNACell Metabolism, 2008
- Selective versus Total Insulin Resistance: A Pathogenic ParadoxCell Metabolism, 2008
- Class B type I scavenger receptor is responsible for the high affinity cholesterol binding activity of intestinal brush border membrane vesiclesBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2007